Gary Bloomgren

2.9k citations
17 papers · 2.1k indexed · 1 hit paper · h-index 12

Gary Bloomgren

16 papers receiving 2.1k citations

Hit Papers

Risk of Natalizumab-Associated Progressive Multifocal Leu...8782012202620162021250500750

Peers

Gary Bloomgren
Comparison fields: 5 of 80
  • Pathology and Forensic Medicine 930
  • Oncology 1.1k
  • Endocrinology, Diabetes and Metabolism 425
  • Immunology 313
  • Neurology 217
Replace James Scanlon with:
James Scanlon United States
Barry Ticho United States
Woo Chan Park South Korea
Christine G. Lian United States
Masanori Tsuchida Japan
Kammi Henriksen United States
Woo Jin Lee South Korea
JC Lee United States
Gaye Hafez United States
Philipp B. Staber Austria
Gary Bloomgren relative to James Scanlon United States James Scanlon's profile →
Citations per field
00.5×1.5×1.9×
James Scanlon · 1×
Citations per year

Countries citing papers authored by Gary Bloomgren

Since Specialization
Citations

This map shows the geographic impact of Gary Bloomgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bloomgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bloomgren more than expected).

Fields of papers citing papers by Gary Bloomgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bloomgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bloomgren. The network helps show where Gary Bloomgren may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary Bloomgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Bloomgren Line = papers co-authored together Gary Bloomgren links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20204
2 201684
3 201575
4 2014306
5 201490
6 201320
7 201264
8
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathybreakdown →
2012878
9 20122
10 20120
11 20128
12 20124
13 201211
14 2011116
15 2011102
16 2009349
17 200823

About Gary Bloomgren

Gary Bloomgren is a scholar working on Family Practice, Oncology and Pathology and Forensic Medicine, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include Polyomavirus and related diseases (9 papers), Full-Duplex Wireless Communications (6 papers), Multiple Sclerosis Research Studies (4 papers), Pancreatitis Pathology and Treatment (4 papers), Reproductive System and Pregnancy (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (930 citations), Oncology (1.1k citations) and Endocrinology, Diabetes and Metabolism (425 citations). Gary Bloomgren has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Sandra Richman, Tatiana Plavina, Meena Subramanyam, Carmen Bozic, Rebecca Noel, Daniel Braun, Sophia Lee, Alfred Sandrock, James Scanlon and Ruth E. Patterson. Their work appears in journals such as Neurology, Annals of Neurology, Diabetes Obesity and Metabolism, Drug Safety and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026